
Kairos Pharma to Present at LD Micro Invitational, Highlighting Clinical Progress in Oncology
Kairos Pharma CEO Dr. John Yu will present at the LD Micro Invitational on May 18, 2026, providing updates on the company's clinical program and partnering activities for its lead candidate ENV-105 targeting CD105 in multiple cancers.
Read full story
























